Change in cardiovascular risk profile by echocardiography in medium-risk elderly hypertensives

Journal of Human Hypertension

Volumn 17, Issue 2, 2003, Pages 101-106

  Cuspidi, C ^a   Michev, L ^a   Severgnini, B ^a   Meani, S ^a   Fusi, V ^a   Valerio, C ^a   Bertazzoli, G ^a   Magrini, F ^a   Zanchetti, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cardiovascular risk stratification; Echocardiography; Elderly; Left ventricular hypertrophy

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; AGING; ANAMNESIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; ELDERLY CARE; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; WORLD HEALTH ORGANIZATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 0037291497     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001507     Document Type: Article

References (32)

1. Collins R et al. Blood pressure, stroke, and coronary heart disease. Part 2: Short term reductions in blood pressure overview of randomized drugs trials in their epidemiological context. Lancet 1990; 335: 827-838.
2. Moser M, Herbert P. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1224-1218.
3. Weber MA, Julius S. The challenge of very mild hypertension, should treatment be sooner or later. Am J Hypertens 1998; 11: 1495-1496.
4. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 2000; 35: 539-543.
5. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
6. Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999: 17: 151-183.
7. Levy D et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
8. Casale PN et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Arch Intern Med 1986; 105: 173-178.
9. Levy D et al. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990; 81: 815-820.
10. Devereux RB et al. Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as reference standard. J Am Coll Cardiol 1984; 3: 82-87.
11. Liu JE, Devereux RB. Clinical assessment of cardiac hypertrophy. In: Sheridan DJ (ed). Left Ventricular Hypertrophy. Churchill Livingstone, London, 1998, pp 11-16.
12. Lakatta EG. Similar myocardial effects of aging and hypertension. Eur Heart J 1990; 11 (Suppl G): 29-38.
13. Pearson AG, Gudipati CV, Labovitz AJ. Effects of aging on left ventricular structure and function. Am Heart J 1991; 121: 871-875.
14. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
15. Hammond I et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: 639-650.
16. De Simone G et al. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and the impact of overweight. J Am Coll Cardiol 1992; 20: 1251-1260.
17. Cuspidi C et al. Lack of correlation between left ventricular mass and diameter of left main coronary artery trunk in hypertensive patients. Am J Hypertens 1999; 12: 1163-1168.
18. Schillaci G et al. Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol 1994; 74: 714-719.
19. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of left ventricular hypertrophy: Test performance in relation to definition of hypertrophy and presence of obesity. J Am Coll Cardiol 1996; 27: 124-131.
20. De Simone G et al. Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056-1062.
21. Ganau A et al. Patterns of left ventricular geometry and geometric remodelling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558.
22. De Simone G, Schillaci G, Palmieri V, Devereux RB. Should all patients with hypertension have echocardiography? J Hum Hypertens 2000; 14: 417-421.
23. Abergel E, Chatellier G, Battaglia C, Menard J. Can echocardiography identify mildly hypertensive patients at high risk, left untreated based on current guidelines? J Hypertens 1999; 17: 817-824.
24. Cuspidi C et al. Cardiovascular risk stratification in hypertensive patients: Impact of echocardiography and carotid ultrasonography. J Hypertens 2001; 19: 375-380.
25. Cuspidi C et al. Influence of different echocardiographic criteria for detection of left ventricular hypertrophy on cardiovascular risk stratification in recently diagnosed hypertensives. J Hum Hypertens 2001; 15: 619-625.
26. Cuspidi C et al. on behalf of the APROS Investigators. The role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: The APROS Study (Assessment of Prognostic Risk Observational Survey). J Hypertens 2002; 20: 1307-1314.
27. Schillaci G et al. Change in cardiovascular risk profile by echocardiography in low or medium risk hypertension. J Hypertens 2002: 20: 1519-1525.
28. De Simone G et al. Relation of hemodynamics and risk factors to ventricular-vascular interactions in the elderly: The Cardiovascular Health Study. J Hypertens 2001; 19: 1893-1903.
29. Coca A et al, on behalf of the VITAE investigators. The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension. The VITAE study. J Hypertens 1999; 17: 1471-1480.
30. Wachtell K et al. Impact of different partition values on prevalence of left ventricular hypertrophy and concentric geometry in a large hypertensive population in the LIFE study. Hypertension 2000; 35: 6-12.
31. Schillaci G et al. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580-586.
32. Liao Y et al. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29: 641-647.